Mike Blue

Mike Blue, CEO of HistoSonics, shares his fascinating journey from a garage-built ultrasound prototype to an FDA-approved cancer treatment device. He discusses how converging sound waves create bubble clouds that destroy tumors non-invasively. After a setback with a failed clinical trial, he rebranded the technology and attracted funding. Blue also reveals insights from the pivotal HOPE for Liver trial, showcasing impressive results and patient outcomes, while addressing challenges in scaling their innovative treatment for various cancers.